The ascendancy of Viagra and its impact on the drug landscape presents a complex question for traders. While the initial sales figures were impressive, the patent has ended, leading to a wave of copycat alternatives that are chipping away at profit. In addition, the industry is facing issues related to demographic trends and changing healthcare reg